Once the substance enters the capillaries surrounding the stomach and small intestines, it enters passageways that lead to the portal vein, which passes through the liver and branches out into the capillaries
Regular clinical assessment can determine whether B12 therapy remains appropriate rather than focusing solely on serum levels
In these vessels, occlusion syndrome and occlusion-like syndrome development and BPC 157 therapy, and the activation of the collateral pathways to mobilize trapped blood volume via the azygos vein was shown to play a particular role as a rescuing pathway [14,15,16,17,18,19,20,21,22,23]
Likewise, it has been theorized that this bypassing key appears to be an effect of the essential endothelial protective capacity of BPC 157
Expected Timeline for Symptom Improvement It may take a few weeks to a few months to see symptom improvements with oral B12